These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34580780)

  • 1. Biomarkers in Neuroblastoma: An Insight into Their Potential Diagnostic and Prognostic Utilities.
    Shawraba F; Hammoud H; Mrad Y; Saker Z; Fares Y; Harati H; Bahmad HF; Nabha S
    Curr Treat Options Oncol; 2021 Sep; 22(11):102. PubMed ID: 34580780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.
    Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H
    Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.
    Gholamin S; Mirzaei H; Razavi SM; Hassanian SM; Saadatpour L; Masoudifar A; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):866-879. PubMed ID: 28145567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
    Cavalli E; Ciurleo R; Petralia MC; Fagone P; Bella R; Mangano K; Nicoletti F; Bramanti P; Basile MS
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32155795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroblastoma.
    Shah S; Ravindranath Y
    Indian J Pediatr; 1998; 65(5):691-705. PubMed ID: 10773924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
    Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
    Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
    BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest to develop an effective therapy for neuroblastoma.
    Bhoopathi P; Mannangatti P; Emdad L; Das SK; Fisher PB
    J Cell Physiol; 2021 Nov; 236(11):7775-7791. PubMed ID: 33834508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma.
    Pan LJ; Chen JL; Wu ZX; Wu YM
    Technol Cancer Res Treat; 2021; 20():15330338211039132. PubMed ID: 34469238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
    Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
    Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
    [No Abstract]   [Full Text] [Related]  

  • 12. A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma.
    Wang Z; Cheng H; Xu H; Yu X; Sui D
    Cancer Biomark; 2020; 28(3):275-284. PubMed ID: 32176634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal hsa-piR1089 promotes proliferation and migration in neuroblastoma via targeting KEAP1.
    Wang H; Shi B; Zhang X; Shen P; He Q; Yin M; Pan Y; Ma J
    Pathol Res Pract; 2023 Jan; 241():154240. PubMed ID: 36436316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin-specific protease 22 is associated with poor prognosis in neuroblastoma.
    Zhibo Q; Lianxin L
    Adv Clin Exp Med; 2020 Mar; 29(3):295-300. PubMed ID: 32216173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strike against indolent neuroblastoma.
    Cook A; Bernstein E
    EBioMedicine; 2020 Oct; 60():103000. PubMed ID: 32977162
    [No Abstract]   [Full Text] [Related]  

  • 16. Polymorphisms of glucose-regulated protein 78 and clinical relevance of neuroblastoma: Risk and prognosis.
    Zhang J; Wang J; Liu Q; Gao J; Wang Q
    J Cancer Res Ther; 2016; 12(3):1178-1183. PubMed ID: 28054532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The connections between neural crest development and neuroblastoma.
    Jiang M; Stanke J; Lahti JM
    Curr Top Dev Biol; 2011; 94():77-127. PubMed ID: 21295685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Hematol Oncol Clin North Am; 2010 Feb; 24(1):65-86. PubMed ID: 20113896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor DNA in neuroblastoma.
    Wei M; Ye M; Dong K; Dong R
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28311. PubMed ID: 32729220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
    Dhamdhere MR; Spiegelman VS
    Front Immunol; 2024; 15():1385875. PubMed ID: 38660306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.